Novartis has obtained the US Food and Drug Administration (FDA) approval for a new 13.3 mg/24 h dosage strength of its Exelon Patch (rivastigmine transdermal system), designed to treat patients with mild to moderate Alzheimer's disease. ...
Tags: Alzheimer's disease, Novartis Pharmaceuticals, Exelon Patch
UnitedHealthcare's Golden Rule Insurance has unveiled a critical illness insurance plan for individuals and families, to offer cash payments to participants who are diagnosed with serious illnesses or health conditions. As per the terms ...
Tags: UnitedHealthcare, Golden Rule Insurance, critical illness insurance